Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Entera Bio (ENTX) Return on Invested Capital (2021 - 2024)

Entera Bio has reported Return on Invested Capital over the past 4 years, most recently at 0.01% for Q4 2024.

  • For the quarter ending Q4 2024, Return on Invested Capital changed 0.0% year-over-year to 0.01%, compared with a TTM value of 0.01% through Dec 2024, changed 0.0%, and an annual FY2024 reading of 0.01%, changed 0.0% over the prior year.
  • Return on Invested Capital came in at 0.01% for Q4 2024, down from 0.01% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q4 2021 to a low of 0.01% in Q3 2023.
  • Median Return on Invested Capital over the past 4 years was 0.01% (2021), compared with a mean of 0.01%.
  • The largest YoY upside for Return on Invested Capital was 0bps in 2022 against a maximum downside of -1bps in 2022.
  • Over 4 years, Return on Invested Capital stood at 0.0% in 2021, then tumbled by -106bps to 0.01% in 2022, then decreased by -6bps to 0.01% in 2023, then dropped by -23bps to 0.01% in 2024.
  • Per Business Quant, the three most recent readings for ENTX's Return on Invested Capital are 0.01% (Q4 2024), 0.01% (Q3 2024), and 0.01% (Q4 2023).